Daewoong to put major efforts for entry of urologic market.

Daewoong has recently launched Bearfina (finasteride) for the treatment of prostate enlargement by blocking a DHT (dihydrotestosterone) production, a causing molecule of the prostate enlargement, thus initiating an entry of the urological drug markets.

The company says that Bearfina shows an improvement of the prostate enlargement, reduction of an acute urinary retention and prevention of a ...